Our global Life Sciences practice comprises a multi-disciplinary team. We act for companies and their investors across the industry, including in the pharmaceuticals, biotech, veterinary, medtech, diagnostics and healthcare sectors.
The practice operates on a cross-border basis and covers
the full spectrum of legal support. We advise on mergers and acquisitions,
commercial transactions (including licensing and collaborations), IP (both
contentious and non-contentious), capital markets and finance, regulatory and
dispute resolution. Our international network ensures that we have a ready
resource of expertise in a number of jurisdictions, including those in emerging
markets, and that we are well positioned to advise on cross-border work.
We have won a reputation for providing far-sighted advice
to some of the world’s leading life science companies – including
GlaxoSmithKline, Pfizer, UCB, Merck, Bayer and Novartis.
“Highly commended life sciences specialists in jurisdictions including France and the UK. Notable corporate experience, covering M&A, capital markets and commercial transactions. Clients include high-profile pharmaceutical, biotechnology and medical device companies. Highlighted for its patent practice and ability to handle European strategy and cross-border infringement litigation.”
Chambers Europe 2014 (Life Sciences: Europe-wide)
Well known across Europe and Asia, with high-profile offices in France, the UK, Belgium, Luxembourg, Slovakia and China. Advises on transactional and contentious IP matters.
Chambers Global 2015 (Intellectual Property: Global-wide)
“A genuine team that all mucks in and works together.”
Clients quoted in Chambers & Partners Europe 2013 (Life Sciences: Europe-wide)